Attached files
file | filename |
---|---|
EX-31.2 - EX-31.2 - Cullinan Oncology, Inc. | cgem-ex312_8.htm |
EX-31.1 - EX-31.1 - Cullinan Oncology, Inc. | cgem-ex311_9.htm |
EX-23.1 - EX-23.1 - Cullinan Oncology, Inc. | cgem-ex231_521.htm |
EX-4.3 - EX-4.3 - Cullinan Oncology, Inc. | cgem-ex43_384.htm |
EX-4.2 - EX-4.2 - Cullinan Oncology, Inc. | cgem-ex42_520.htm |
EX-3.2 - EX-3.2 - Cullinan Oncology, Inc. | cgem-ex32_385.htm |
EX-3.1 - EX-3.1 - Cullinan Oncology, Inc. | cgem-ex31_386.htm |
10-K - 10-K - Cullinan Oncology, Inc. | cgem-10k_20201231.htm |
Exhibit 32.1
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Cullinan Oncology, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of their knowledge:
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: March 30, 2021 |
|
By: |
/s/ Owen Hughes |
|
|
|
Owen Hughes |
|
|
|
President and Chief Executive Officer (Principal Executive Officer) |
Date: March 30, 2021 |
|
By: |
/s/ Jeffrey Trigilio |
|
|
|
Jeffrey Trigilio |
|
|
|
Chief Financial Officer (Principal Financial and Accounting Officer) |
1
ACTIVE/108795781.1